Reversal of immunosuppression in cutaneous T cell lymphoma by anti-CTLA-4 antibody

被引：0
|
作者：
Berger, C. L. [1 ]
Girardi, M. [1 ]
Tigelaar, R. [1 ]
Edelson, R. L. [1 ]
机构：
[1] Yale Univ, New Haven, CT USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2007年 / 127卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
698
引用
收藏
页码：S117 / S117
页数：1
相关论文
共 50 条
  • [1] Anti-CTLA-4 Therapy Expands T Cell Range
    不详
    SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (254)
  • [2] Targeted delivery of anti-CTLA-4 antibody downregulates T cell function in vitro and in vivo
    Rao, S
    Vasu, C
    Martinez, O
    Kaithamana, S
    Prabhakar, BS
    Holterman, MJ
    CLINICAL IMMUNOLOGY, 2001, 101 (02) : 136 - 145
  • [3] Anti-CTLA-4 Antibody Adjuvant Therapy in Melanoma
    Eggermont, Alexander M. M.
    Testori, Alessandro
    Maio, Michele
    Robert, Caroline
    SEMINARS IN ONCOLOGY, 2010, 37 (05) : 455 - 459
  • [4] Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma
    Lipson, Evan J.
    Drake, Charles G.
    CLINICAL CANCER RESEARCH, 2011, 17 (22) : 6958 - 6962
  • [5] Clinical Development of the Anti-CTLA-4 Antibody Tremelimumab
    Ribas, Antoni
    SEMINARS IN ONCOLOGY, 2010, 37 (05) : 450 - 454
  • [6] T-cell repertoire turnover induced by anti-CTLA-4 antibody treatment in cancer patients
    Fong, Lawrence H.
    Cha, Edward
    Klinger, Mark
    Hou, Yafei
    Cummings, Craig
    Ribas, Antoni
    Faham, Malek
    CANCER RESEARCH, 2014, 74 (19)
  • [7] Effect of anti-CTLA-4 antibody treatment on T-cell repertoire evolution in treated cancer patients
    Cha, Edward
    Hou, Yafei
    Klinger, Mark
    Cummings, Craig
    Faham, Malek
    Ribas, Antoni
    Fong, Lawrence
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Neutropenia in a Patient Treated With Ipilimumab (anti-CTLA-4 Antibody)
    Akhtari, Mojtaba
    Waller, Edmund K.
    Jaye, David L.
    Lawson, David H.
    Ibrahim, Ramy
    Papadopoulos, Nicholas E.
    Arellano, Martha L.
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (03) : 322 - 324
  • [9] Assessment of pharmacology and toxicology of anti-CTLA-4 antibody (ADU-1604) in nonhuman primates and evaluation of local anti-CTLA-4 application
    Hendriks, Maaike
    Kreijtz, Joost
    Vink, Paul
    Hulsik, David Lutje
    Lodewijks, Imke
    Bertens, Astrid
    van de Crommert, Jos
    Habraken, Maurice
    Janssen, Wout
    Stammen-Vogelzang, Judith
    Gardner, Olivia
    Deng, Weiwen
    Leong, Meredith
    McWhirter, Sarah
    van Eenennaam, Hans
    van Elsas, Andrea
    CANCER RESEARCH, 2018, 78 (13)
  • [10] Immunological Characteristics of Colitis Associated with Anti-CTLA-4 Antibody Therapy
    Bamias, Giorgos
    Delladetsima, Ioanna
    Perdiki, Marina
    Siakavellas, Spyros I.
    Goukos, Dimitrios
    Papatheodoridis, George V.
    Daikos, George L.
    Gogas, Helen
    CANCER INVESTIGATION, 2017, 35 (07) : 443 - 455
12345